Business
ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
Results from the at-home test kit are available to HCPs and their patients through 1health LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC), the

About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"\nResults from the at-home test kit are available to HCPs and their patients through 1health\n\n\n LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, launches the Niagen+ NAD+ Test Kit*, now available exclusively through the company’s healthcare practitioner (HCP) channel. This innovative test kit provides practitioners with a reliable method for measuring patient blood NAD+ levels, helping them create more personalized and effective patient protocols using ChromaDex’s NAD+-boosting HCP products, Tru Niagen® and Niagen+.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240723490080/en/ChromaDex launches Niagen+ NAD+ Test Kit, one of the most reliable methods for patients to measure and track their NAD+ levels (Photo: Business Wire)\nTru Niagen is a suite of oral dietary supplements featuring Niagen (patented nicotinamide riboside or NR), the most efficient and high-quality NAD+ precursor available. Niagen+ features pharmaceutical-grade Niagen (patented nicotinamide riboside chloride or NRC) and will soon be available as Niagen IV and injections exclusively at clinics from U.S. FDA 503B-registered outsourcing facilities with a prescription. Representing a significant advancement in intravenous NAD+ therapy, practitioners are eager to provide Niagen IV therapy to patients.\n\n\nRob Fried, CEO of ChromaDex and Founder of Tru Niagen, noted, \"Our healthcare practitioners have requested a tool to measure blood NAD+ levels, and we believe this is the best product now available on the market.\"\n\n\nSetting a new standard in analytical NAD+ measurement methods, the Niagen+ NAD+ Test Kit features cutting-edge dried blood spot (DBS) assay technology, ensuring the stability of NAD+ samples during transport for precise and accurate results. Other test kits use a less reliable DBS card, which requires adding a fixer solution to stabilize NAD+, which often degrades during the DBS drying process. With this innovative Niagen+ NAD+ test, HCPs can provide patients with personalized and effective protocols by more accurately tracking NAD+ changes over time.\n\n\nKey Niagen+ NAD+ Test Kit features:\n\n\n\nInnovative test card technology: A unique blood spot test card mai...